MP21-02 TUMOR ASSOCIATED NEUTROPHILS SUPPRESS CD8+ T CELLS RESPONSIVENESS TO DETERIORATE SURVIVAL IN HUMAN RENAL CANCER

Huyang Xie,Junyu Zhang,Yongqiang Huang,Yeqing Huang,Qianwei Xing,Jiejie Xu,Dingwei Ye
DOI: https://doi.org/10.1097/01.ju.0000555530.56881.f0
2019-01-01
Abstract:You have accessJournal of UrologyKidney Cancer: Basic Research & Pathophysiology II (MP21)1 Apr 2019MP21-02 TUMOR ASSOCIATED NEUTROPHILS SUPPRESS CD8+ T CELLS RESPONSIVENESS TO DETERIORATE SURVIVAL IN HUMAN RENAL CANCER Huyang Xie*, Junyu Zhang, Yongqiang Huang, Yeqing Huang, Qianwei Xing, Jiejie Xu, and Dingwei Ye Huyang Xie*Huyang Xie* More articles by this author , Junyu ZhangJunyu Zhang More articles by this author , Yongqiang HuangYongqiang Huang More articles by this author , Yeqing HuangYeqing Huang More articles by this author , Qianwei XingQianwei Xing More articles by this author , Jiejie XuJiejie Xu More articles by this author , and Dingwei YeDingwei Ye More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000555530.56881.f0AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: Neutrophils are prominent components of solid tumors and exhibit distinct phenotypes in different tumor microenvironment. However, the nature, regulation, function and clinical relevance of neutrophils in human renal cancer are presently unknown. We investigated clinical relevance, phenotypes, and functional features of renal cancer–infiltrating neutrophils and their crosstalk with CD8+ T cells. METHODS: CD66b+ and CD8+ cell infiltration was analyzed by IHC on a tissue microarray including 237 evaluable renal cancer samples. Flow cytometry analyses were performed to examine levels and phenotype of neutrophils in samples from patients. Kaplan-Meier plots for overall survival were performed using the log-rank test. Neutrophils and T cells were isolated, stimulated and/or cultured for in vitro and in vivo regulation and function assays. RESULTS: Patients with renal cancer showed a significantly higher neutrophil infiltration in tumors. These tumor infiltrating neutrophils showed an activated CD54+ phenotype and expressed high level galectin-9 (Gal-9). Neutrophils activated by tumors prolonged their lifespan and strongly expressed Gal-9 proteins with similar phenotype to their status in renal cancer, and significant correlations were found between the levels of Gal-9 and CD54 on tumor-infiltrating neutrophils. Moreover, these Gal-9+ neutrophils in tumors were associated with disease progression and reduced patient survival. Tumor-derived TGF-β activated neutrophils and induced neutrophil Gal-9 expression. The activated Gal-9+ neutrophils effectively suppressed normal T-cell immunity in vitro and contributed to the growth and progression of human renal cancer in vivo; the effect could be reversed by blocking Gal-9 or Tim-3 on CD8+ T cells. CONCLUSIONS: Our results illuminate a novel mechanism of Gal-9 expression on tumor-activated neutrophils in renal cancer, and also provide functional evidence for these novel TGF-β-Gal-9-Tim-3 pathways to prevent, and to treat this immune tolerance feature of renal cancer. Source of Funding: none Nantong, China, People’s Republic of; Shanghai, China, People’s Republic of; Nantong, China, People’s Republic of; Shanghai, China, People’s Republic of© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e292-e293 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Huyang Xie* More articles by this author Junyu Zhang More articles by this author Yongqiang Huang More articles by this author Yeqing Huang More articles by this author Qianwei Xing More articles by this author Jiejie Xu More articles by this author Dingwei Ye More articles by this author Expand All Advertisement PDF downloadLoading ...
What problem does this paper attempt to address?